-
Assent Process For Pediatric Trials An ‘Experiment For All Of Us’
Clinical Research News | Despite regulatory and congressional efforts to protect human research subjects that date back 75 years, ethical dilemmas concerning the participation of pediatric populations in clinical trials persist with no consensus on several key issues—among them the age at which children are too young to understand what they’re agreeing to, and how to respect nonverbal expressions of dissent.
Oct 11, 2022
-
Select European Research Institutes Become the First to Join International Data Network
Clinical Research News | Research institutes representing five western European countries—Finland, Germany, Norway, Spain, and Sweden—will become the first to join the Federated European Genome-phenome Archive, an international distributed data network designed to share highly-sensitive human ’omics data internationally.
Oct 6, 2022
-
University College London’s Dr. Anna David on Increasing the Representation of Pregnant Patients in Clinical Trials
Clinical Research News | University College London’s Dr. Anna David speaks about the obstacles facing pregnant patients in today’s medical landscape and the past and present strides made to increase their representation in clinical research, all in the latest episode of the Scope of Things podcast.
Oct 4, 2022
-
Finding More Patients for Clinical Trials by Unlocking Intelligence from Patient Records
Clinical Research News | Novel artificial intelligence methods have recently been proven clinically valid and valuable for capturing target patient populations investigated by a clinical trial. The intelligence and outputs from novel AI methods benefit clinicians by enabling an ecosystem based on knowledge discovery and sharing in a privacy-preserving manner.
Sep 30, 2022
-
Singapore’s Largest Respiratory Medicine Research Collaboration, New Brain Health Intervention Research Initiative, More
Clinical Research News | A first-of-its-kind benchtop platform that enables researchers to assess multiple critical quality attributes of cell samples in a single automated workflow; a prospective pan-tumor therapeutic trial designed to evaluate the efficacy and safety of numerous FDA-approved cancer therapies in new, biomarker-guided patient populations; and more.
Sep 29, 2022
